BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1124 related articles for article (PubMed ID: 25720354)

  • 1. The ins and outs of MHC class II-mediated antigen processing and presentation.
    Roche PA; Furuta K
    Nat Rev Immunol; 2015 Apr; 15(4):203-16. PubMed ID: 25720354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A central role for HSC70 in regulating antigen trafficking and MHC class II presentation.
    Deffit SN; Blum JS
    Mol Immunol; 2015 Dec; 68(2 Pt A):85-8. PubMed ID: 25953005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mhc-guided processing: binding of large antigen fragments.
    Sercarz EE; Maverakis E
    Nat Rev Immunol; 2003 Aug; 3(8):621-9. PubMed ID: 12974477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-independent acquisition of MHC class II molecules by human T lymphocytes.
    Undale AH; van den Elsen PJ; Celis E
    Int Immunol; 2004 Oct; 16(10):1523-33. PubMed ID: 15351785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Processing and MHC class II presentation of exogenous soluble antigen involving a proteasome-dependent cytosolic pathway in CD40-activated B cells.
    Becker HJ; Kondo E; Shimabukuro-Vornhagen A; Theurich S; von Bergwelt-Baildon MS
    Eur J Haematol; 2016 Aug; 97(2):166-74. PubMed ID: 26561366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MHC class II molecules on the move for successful antigen presentation.
    Rocha N; Neefjes J
    EMBO J; 2008 Jan; 27(1):1-5. PubMed ID: 18046453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class II MHC peptide loading by the professionals.
    Bryant P; Ploegh H
    Curr Opin Immunol; 2004 Feb; 16(1):96-102. PubMed ID: 14734116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters.
    Bosch B; Heipertz EL; Drake JR; Roche PA
    J Biol Chem; 2013 May; 288(19):13236-42. PubMed ID: 23532855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo.
    Beers C; Burich A; Kleijmeer MJ; Griffith JM; Wong P; Rudensky AY
    J Immunol; 2005 Feb; 174(3):1205-12. PubMed ID: 15661874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trafficking of MHC class II molecules in the late secretory pathway.
    Hiltbold EM; Roche PA
    Curr Opin Immunol; 2002 Feb; 14(1):30-5. PubMed ID: 11790530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
    Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
    J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane specializations and endosome maturation in dendritic cells and B cells.
    Boes M; Cuvillier A; Ploegh H
    Trends Cell Biol; 2004 Apr; 14(4):175-83. PubMed ID: 15066635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular transport of MHC class II molecules.
    Neefjes JJ; Ploegh HL
    Immunol Today; 1992 May; 13(5):179-84. PubMed ID: 1642756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell biology of antigen presentation.
    Neefjes JJ; Momburg F
    Curr Opin Immunol; 1993 Feb; 5(1):27-34. PubMed ID: 7680870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antigen Processing and Presentation Machinery in Lymphatic Endothelial Cells.
    Santambrogio L; Berendam SJ; Engelhard VH
    Front Immunol; 2019; 10():1033. PubMed ID: 31134089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.